Tripoli Virus Insights

Erin discusses the challenges surrounding vaccine development for the rare Tripoli virus, highlighting the limited duration of immunity observed in clinical trials. With only a small percentage of participants maintaining high antibody levels after a year, the focus shifts to prevention and surveillance strategies. The conversation also touches on unpredictable weather patterns, reminiscing about personal experiences with unexpected snow during significant events.